ORCHPHARMA

ORCHID PHARMA

Small Cap BSE: 524372 NSE: ORCHPHARMA
₹319.00
7.3 (2.34%)
As on 30 September, 2022 | 01:21

Orchid Pharma Share Price

Orchid Pharma Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in ORCHID PHARMA

Start SIP

Orchid Pharma Share Returns

  • Over 1 Month 1.01%
  • Over 3 Month 12.54%
  • Over 6 Month 17.18%
  • Over 1 Year -25.87%

Orchid Pharma Key Statistics

P/E Ratio 93.4
PEG Ratio 0.8
Market Cap Cr 1,302
Price to Book Ratio 2
EPS -1.3
Dividend 0
Relative Strength Index 48.13
Money Flow Index 59.57
MACD Signal 3.01
Average True Range 15

Orchid Pharma Investment Rating

  • Master Rating:
  • Orchid Pharma has an operating revenue of Rs. 598.23 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of -10% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 32%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 47 which is a POOR score indicating inconsistency in earnings, a RS Rating of 34 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 125 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Orchid Pharma Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 13118015912296120
Operating Expenses Qtr Cr 1191511431149197
Operating Profit Qtr Cr 1229167424
Depreciation Qtr Cr 222720202020
Interest Qtr Cr 847101112
Tax Qtr Cr 000000
Net Profit Qtr Cr -14-2-932-26-27

Orchid Pharma Technicals

EMA & SMA

Current Price
318.5
6.8 (2.18%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 322.77
  • 50 Day
  • 318.45
  • 100 Day
  • 318.21
  • 200 Day
  • 328.94
  • 20 Day
  • 324.64
  • 50 Day
  • 321.02
  • 100 Day
  • 307.27
  • 200 Day
  • 328.64

Orchid Pharma Resistance and Support

PIVOT
₹312.64
Resistance
First Resistance 317.07
Second Resistance 322.44
Third Resistance 326.87
RSI 48.13
MFI 59.57
MACD Single Line 3.01
MACD 0.38
Support
First Resistance 307.27
Second Resistance 302.84
Third Resistance 297.47

Orchid Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 1,368 136,800 100
Week 2,752 275,220 100
1 Month 8,410 840,962 100
6 Month 13,364 967,974 72.43

Orchid Pharma Result Highlights

Orchid Pharma Synopsis

NSE-Medical-Diversified

Orchid Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 556.97 Cr. and Equity Capital is Rs. 40.82 Cr. for the Year ended 31/03/2022. Orchid Pharma Ltd. is a Public Limited Listed company incorporated on 01/07/1992 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24222TN1992PLC022994 and registration number is 022994.
Market Cap 1,302
Sales 592
Shares in Float 0.41
No of funds 18
Yield
Book Value 1.92
U/D Vol ratio 1.1
LTDebt / Equity 31
Alpha -0.08
Beta 0.83

Orchid Pharma

Owner NameJun-22Mar-22Dec-21Sep-21
Promoters 89.96%90%90%
Mutual Funds 2.45%2.45%2.45%
Insurance Companies
Foreign Portfolio Investors 1.48%1.61%1.78%
Financial Institutions/ Banks 0.52%0.52%0.9%
Individual Investors 3.69%3.34%2.83%
Others 1.9%2.08%2.04%

Orchid Pharma Management

Name Designation
Mr. Ram Gopal Agarwal Chairman & Non-Exe.Director
Mr. Manish Dhanuka Managing Director
Mr. Mridul Dhanuka Whole Time Director
Mr. Arun Kumar Dhanuka Non Executive Director
Mrs. Tanu Singla Independent Director
Dr. Dharam Vir Independent Director
Mr. Manoj Kumar Goyal Independent Director
Mr. Mudit Tandon Independent Director

Orchid Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Orchid Pharma Corporate Action

Date Purpose Remarks
2022-08-10 Quarterly Results
2022-05-12 Audited Results
2022-02-12 Quarterly Results
2021-11-14 Quarterly Results
2021-08-13 Quarterly Results

Orchid Pharma MF Shareholding

Name Amount(cr)
Nippon India Pharma Fund - Growth 4588

Orchid Pharma FAQs

What is Share Price of Orchid Pharma ?

Orchid Pharma share price is ₹319 As on 30 September, 2022 | 01:07

What is the Market Cap of Orchid Pharma ?

The Market Cap of Orchid Pharma is ₹1302 Cr As on 30 September, 2022 | 01:07

What is the P/E ratio of Orchid Pharma ?

The P/E ratio of Orchid Pharma is 93.4 As on 30 September, 2022 | 01:07

What is the PB ratio of Orchid Pharma ?

The PB ratio of Orchid Pharma is 2 As on 30 September, 2022 | 01:07

Q1FY23